Latest Capital Raises News

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

Redivium Limited is progressing recapitalisation efforts and revising its UK lithium-ion battery recycling project plans amid ongoing ASX suspension. The company is engaging Australian investors to support reinstatement and updating feasibility studies following site changes.

Alvo Minerals has raised $2.26 million through a placement to accelerate drilling and exploration at its Palma Copper-Zinc Project in Brazil, including the promising new Touro Prospect.

Redivium Limited has advanced its battery recycling ambitions with a binding offtake agreement alongside strategic funding plans, despite ongoing ASX suspension. The company’s new partnership with WMC Energy BV marks a pivotal step toward commercialising its UK recycling facility.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

Greenvale Energy Limited has closed its Share Purchase Plan, offering shareholders shares at $0.044 each with free attaching options exercisable at $0.07 until November 2026. The final subscription outcome will be announced on December 4.

Black Bear Minerals has reported exceptional high-grade silver rock chip samples up to 3,100g/t outside its existing Shafter Mineral Resource in Texas, revealing promising multi-commodity potential and plans for expanded exploration.

Havilah Resources has secured a binding term sheet with Sandfire Resources for a potential $210 million earn-in at Kalkaroo, while reporting high-grade uranium results and raising $2 million in a share placement.

Provaris Energy’s 2025 AGM highlights strategic progress in hydrogen and CO2 storage technologies, focusing on European market expansion and a refined licensing business model.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Ryman Healthcare has reported its first positive free cash flow in over a decade, driven by cost reductions and stronger sales momentum, while upgrading its sales guidance for FY26.

Redivium Limited has withdrawn its planned European Green Bond issuance amid challenging market conditions and an ongoing ASX suspension, despite securing conditional investor commitments. The company signals a future return to green debt markets when conditions improve.